Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vanesa Gutiérrez Calderón
Observed names:
Vanesa Gutierrez Calderon,
Vanesa Gutierrez-Calderon,
Vanesa Gutiérrez-Calderon,
Vanesa Gutiérrez-Calderón
Institution:
Hospital Regional Universitario de Málaga
Observed institutions:
Hospital Regional Universitario de Málaga,
Hospital Clínico Universitario Virgen de la Victoria,
Instituto de Investigación Biomédica de Málaga
OpenAlex ID:
A5110029516
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
2023
·
H. Borghaei
, F. de Marinis
, et al.
·
Annals of Oncology
·
113
PDF
Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
2026
·
Vanesa Gregorc
, Margarita Majem
, et al.
·
The Lancet Oncology
·
14
Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study
2006
·
Manuel Cobo-Dols
, Silvia Gil-Calle
, et al.
·
Clinical & Translational Oncology
·
4
Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy (NIVOTAX): A TTCC study.
2021
·
Lara Iglesias
, Alberto Carral
, et al.
·
Journal of Clinical Oncology
·
1
Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)—SLCG 10/02.
2016
·
Mariano Provencio
, Ramon de las Penas
, et al.
·
Journal of Clinical Oncology
·
1
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study
2026
·
Lara Iglesias Docampo
, Neus Basté
, et al.
·
European Journal of Cancer
PDF
Safety analysis of lurbinectedin versus topotecan in elderly patients.
2023
·
Vivek Subbiah
, Domenica Lorusso
, et al.
·
Journal of Clinical Oncology
Centrally determined PD-L1 among non-eligible for cisplatin-based chemotherapy recurrent/metastatic head and neck patients (R/M HNSCC pts): Pathology outcomes from the NIVOTAX trial.
2022
·
Lara Iglesias
, Ana Belen Enguita
, et al.
·
Journal of Clinical Oncology
Long-term survival in small-cell lung cancer patients: Extension of the SMALLBRAIN study.
2022
·
Javier Diaz-Santos
, Alexandra Cantero-Gonzalez
, et al.
·
Journal of Clinical Oncology
CLO22-042: Long Survival in Small-Cell Lung Cancer With Central Nervous System Metastasis: Relationship Between Survival and Metastasis Chronology (SMALLBRAIN Project)
2022
·
Javier Diaz-Santos
, Carmen Reyna-Fortes
, et al.
·
Journal of the National Comprehensive Cancer Network
Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin and chemo-radiation in stage III NSCLC. SLCG 10/02.
2018
·
Mariano Provencio-Pulla
, Ramon De Las Penas
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
11
Citation count:
133
H-index:
3
I10-index:
2
Year
Topic
Type